Vault-13

SAMSARA BIOCAPITAL, LLC

PALO ALTO, CA · CIK 1744967 · 13F filing filed 2021-08-17

SEC-registered investment adviser since 2018 · limited liability company

As an employer

US visa salary filings

Job titleFilingsMedianRange
Senior AssociatePalo Alto, CA 2 $187,500 $175,000 – $200,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.

$760.8m reported value +53.2% vs Q1 2021
48positions
72.6%in top 10
7 new 2 added 11 reduced 1 sold out vs Q1 2021

Options: 2 call positions ($49.3m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 GRAPHITE BIO INC COM GRPH GRPH 7,431,623 $228.4m30.02% 30.02% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 7.4m
2 NKARTA INC COM NKTX NKTX 2,034,703 $64.5m8.48% 8.48% UnchangedShares held: Q3 2020 2.0m, Q4 2020 2.0m, Q1 2021 2.0m, Q2 2021 2.0m
3 CHINOOK THERAPEUTICS INC COM ADRO ADRO 3,168,388 $44.7m5.88% 5.88% UnchangedShares held: Q3 2020 0, Q4 2020 3.2m, Q1 2021 3.2m, Q2 2021 3.2m
4 INSTIL BIO INC COM COM 2,145,395 $41.4m5.45% 5.45% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.6m, Q2 2021 2.1m +591.4k +591,370 38.0%
5 FORMA THERAPEUTICS HLDGS INC SHS SHS 1,565,529 $39.0m5.12% 5.12% UnchangedShares held: Q3 2020 1.5m, Q4 2020 1.4m, Q1 2021 1.6m, Q2 2021 1.6m
6 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 1,537,533 $34.1m4.49% 4.49% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.5m
7 SUTRO BIOPHARMA INC COM COM 1,675,579 $31.1m4.09% 4.09% UnchangedShares held: Q3 2020 1.7m, Q4 2020 1.7m, Q1 2021 1.7m, Q2 2021 1.7m
8 RECURSION PHARMACEUTICALS IN CL A RXRX RXRX 775,583 $28.3m3.72% 3.72% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 775.6k
9 RAIN ONCOLOGY INC COM COM 1,637,308 $25.4m3.34% 3.34% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.6m
10 JANUX THERAPEUTICS INC COM JANX JANX 607,949 $15.2m1.99% 1.99% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 607.9k
11 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 169,852 $14.0m1.84% 1.84% UnchangedShares held: Q3 2020 398.0k, Q4 2020 262.6k, Q1 2021 169.9k, Q2 2021 169.9k
12 ACLARIS THERAPEUTICS INC COM ACRS ACRS 794,171 $13.9m1.83% 1.83% ReducedShares held: Q3 2020 2.2m, Q4 2020 1.4m, Q1 2021 1.0m, Q2 2021 794.2k -228.4k -228,441 -22.3%
13 IVERIC BIO INC COM OPHT OPHT 2,125,371 $13.4m1.76% 1.76% ReducedShares held: Q3 2020 3.4m, Q4 2020 2.4m, Q1 2021 2.4m, Q2 2021 2.1m -247.1k -247,105 -10.4%
14 INTERCEPT PHARMACEUTICALS IN COM ICPT ICPT 640,688 $12.8m1.68% 1.68% UnchangedShares held: Q3 2020 403.7k, Q4 2020 403.7k, Q1 2021 640.7k, Q2 2021 640.7k
15 ELEVATION ONCOLOGY INC COM COM 932,239 $12.7m1.66% 1.66% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 932.2k
16 ALLAKOS INC COM ALLKG ALLKG 146,259 $12.5m1.64% 1.64% UnchangedShares held: Q3 2020 192.3k, Q4 2020 146.3k, Q1 2021 146.3k, Q2 2021 146.3k
17 BOLT BIOTHERAPEUTICS INC COM COM 737,459 $11.4m1.50% 1.50% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 737.5k, Q2 2021 737.5k
18 SYROS PHARMACEUTICALS INC COM SYRS SYRS 2,189,199 $10.6m1.39% 1.39% UnchangedShares held: Q3 2020 1.4m, Q4 2020 2.2m, Q1 2021 2.2m, Q2 2021 2.2m
19 VIRACTA THERAPEUTICS INC COM SNSS SNSS 711,039 $8.1m1.06% 1.06% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 831.6k, Q2 2021 711.0k -120.6k -120,586 -14.5%
20 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 1,111,112 $7.3m0.96% 0.96% UnchangedShares held: Q3 2020 1.1m, Q4 2020 1.1m, Q1 2021 1.1m, Q2 2021 1.1m
21 DECIBEL THERAPEUTICS INC COM COM 826,422 $7.1m0.93% 0.93% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 826.4k, Q2 2021 826.4k
22 NOVAVAX INC COM NEW NVAX NVAX 30,160 $6.4m0.84% 0.84% UnchangedShares held: Q3 2020 21.7k, Q4 2020 30.2k, Q1 2021 30.2k, Q2 2021 30.2k
23 AEGLEA BIOTHERAPEUTICS INC COM AGLE AGLE 883,720 $6.2m0.81% 0.81% UnchangedShares held: Q3 2020 883.7k, Q4 2020 883.7k, Q1 2021 883.7k, Q2 2021 883.7k
24 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 300,293 $5.9m0.77% 0.77% AddedShares held: Q3 2020 234.8k, Q4 2020 201.0k, Q1 2021 201.0k, Q2 2021 300.3k +99.2k +99,247 49.4%
25 BCTG ACQUISITION CORP COM COM 500,000 $5.7m0.75% 0.75% UnchangedShares held: Q3 2020 500.0k, Q4 2020 500.0k, Q1 2021 500.0k, Q2 2021 500.0k
26 JIYA ACQUISITION CORP COM CL A COM CL A 507,041 $5.0m0.66% 0.66% UnchangedShares held: Q3 2020 0, Q4 2020 5.2k, Q1 2021 507.0k, Q2 2021 507.0k
27 DAY ONE BIOPHARMACEUTICALS I COM COM 202,500 $4.6m0.61% 0.61% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 202.5k
28 EQUILLIUM INC COM EQ EQ 738,176 $4.3m0.57% 0.57% ReducedShares held: Q3 2020 1.1m, Q4 2020 1.1m, Q1 2021 764.4k, Q2 2021 738.2k -26.2k -26,227 -3.4%
29 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 450,000 $4.0m0.53% 0.53% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 450.0k, Q2 2021 450.0k
30 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 549,250 $3.7m0.49% 0.49% UnchangedShares held: Q3 2020 0, Q4 2020 434.2k, Q1 2021 549.2k, Q2 2021 549.2k
31 TERNS PHARMACEUTICALS INC COM COM 289,068 $3.5m0.47% 0.47% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 497.6k, Q2 2021 289.1k -208.5k -208,487 -41.9%
32 ALBIREO PHARMA INC COM BIOD BIOD 100,000 $3.5m0.46% 0.46% UnchangedShares held: Q3 2020 100.0k, Q4 2020 100.0k, Q1 2021 100.0k, Q2 2021 100.0k
33 ATRECA INC CL A COM BCEL BCEL 396,835 $3.4m0.44% 0.44% UnchangedShares held: Q3 2020 617.6k, Q4 2020 474.9k, Q1 2021 396.8k, Q2 2021 396.8k
34 KALA PHARMACEUTICALS INC COM COM 601,162 $3.2m0.42% 0.42% UnchangedShares held: Q3 2020 451.2k, Q4 2020 601.2k, Q1 2021 601.2k, Q2 2021 601.2k
35 BCLS ACQUISITION CORP COM CL A COM CL A 300,000 $3.2m0.42% 0.42% UnchangedShares held: Q3 2020 0, Q4 2020 300.0k, Q1 2021 300.0k, Q2 2021 300.0k
36 CONSONANCE HFW ACQUISITION C UNIT 99/99/9999 UNIT 99/99/9999 300,000 $3.1m0.41% 0.41% UnchangedShares held: Q3 2020 0, Q4 2020 300.0k, Q1 2021 300.0k, Q2 2021 300.0k
37 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 64,000 $2.5m0.33% 0.33% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 80.0k, Q2 2021 64.0k -16.0k -16,000 -20.0%
38 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 275,169 $2.5m0.33% 0.33% ReducedShares held: Q3 2020 494.2k, Q4 2020 399.2k, Q1 2021 399.2k, Q2 2021 275.2k -124.0k -124,021 -31.1%
39 ODONATE THERAPEUTICS INC COM COM 700,421 $2.4m0.32% 0.32% UnchangedShares held: Q3 2020 815.4k, Q4 2020 815.4k, Q1 2021 700.4k, Q2 2021 700.4k
40 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 732,596 $2.3m0.30% 0.30% ReducedShares held: Q3 2020 0, Q4 2020 1.6m, Q1 2021 1.8m, Q2 2021 732.6k -1.1m -1,098,894 -60.0%
41 LIFESCI ACQUISITION II CORP COM COM 200,000 $2.0m0.26% 0.26% UnchangedShares held: Q3 2020 0, Q4 2020 200.0k, Q1 2021 200.0k, Q2 2021 200.0k
42 KRONOS BIO INC COM KRON KRON 78,131 $1.9m0.25% 0.25% ReducedShares held: Q3 2020 0, Q4 2020 166.2k, Q1 2021 166.2k, Q2 2021 78.1k -88.1k -88,119 -53.0%
43 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 40,550 $1.8m0.24% 0.24% ReducedShares held: Q3 2020 99.6k, Q4 2020 63.8k, Q1 2021 63.8k, Q2 2021 40.5k -23.2k -23,220 -36.4%
44 ALLOVIR INC COM COM 82,336 $1.6m0.21% 0.21% UnchangedShares held: Q3 2020 91.1k, Q4 2020 82.3k, Q1 2021 82.3k, Q2 2021 82.3k
45 BIONTECH SE SPONSORED ADS BNTX BNTX 5,758 $1.3m0.17% 0.17% ReducedShares held: Q3 2020 12.7k, Q4 2020 10.8k, Q1 2021 10.8k, Q2 2021 5.8k -5.0k -5,037 -46.7%
46 NGM BIOPHARMACEUTICALS INC COM NGM NGM 18,225 $359.0k0.05% 0.05% UnchangedShares held: Q3 2020 36.5k, Q4 2020 18.2k, Q1 2021 18.2k, Q2 2021 18.2k
47 CATABASIS PHARMACEUTICALS IN COM NEW CATB CATB 150,000 $317.0k0.04% 0.04% UnchangedShares held: Q3 2020 300.0k, Q4 2020 300.0k, Q1 2021 150.0k, Q2 2021 150.0k
48 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 25,000 $110.0k0.01% 0.01% UnchangedShares held: Q3 2020 25.0k, Q4 2020 25.0k, Q1 2021 25.0k, Q2 2021 25.0k

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
CUREVAC N V CVAC CVAC 95,318 $8.7m95.3k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
NOVAVAX INC NVAX · Call NVAXCall 198,600 $42.2m198.6k shares Unchanged
ALLAKOS INC ALLKG · Call ALLKGCall 83,000 $7.1m83.0k shares Unchanged